Discovery’s Genomics Services, offer flexible and creative problem solving through a diverse range of hybridization and capture platforms, robotic automation, and advanced genomics technologies, our team of experienced scientists are well-equipped to propel your study goals forward.
We support projects spanning the full range of research, including basic, discovery, translational, and clinical, and have the infrastructure to deliver rapid turnaround times even for large-scale studies.
Frequent review and optimization of hybridization techniques to increase capture efficiency and ensure even coverage across targeted regions
50x, 100x, 300x, and custom coverage options
Dual-index 100 base paired-end reads and custom read length options
Massive scale with the world’s largest commercial fleet of NovaSeq X Plus, Illumina NovaSeq 6000 sequencers as well as NextSeqs, MiSeqs, and iSeqs instruments
Optimized low-input WES workflows make the most out of your precious sample material.
Our automated workflows reduce turnaround time and increase reproducibility.
Industry-leading dual RNA and DNA extraction services are available
Rigorous validation and determination of technical specifications for exome and targeted sequencing services
Optimized multi-omic integration with clinical flow, cell biology, molecular pathology, and proteomic services – all under one roof
Access to the world’s largest commercial biorepository to build optimal study cohorts
We support projects spanning basic, discovery, translational, and clinical phases, and we have the capacity to deliver rapid turnaround times even for large-scale studies.
We can develop and validate bespoke targeted and WES assays
Contact us at info@dls.com or click here and we will put you in touch with the right experts to discuss your project.
An Analytical Plan will be compiled by your dedicated project manager. The Analytical Plan details laboratory activities and ensures client alignment prior to any sample processing.
The Analytical Plan will be shared with you for edits and comments. Discovery’s quality standards require that the Analytical Plan is agreed upon and signed off by Discovery and the client prior to any testing being performed.
Your primary contact throughout your project will be your dedicated project manager.
NOTE: Some projects may not require a formal Analytical Plan if deemed out of scope for the nature of the project at Discovery's discretion. This will be discussed with your Project Manager during the initiation of each project.
All sample shipments will require a clearly defined manifest including Protocol/Study identification, sample information, patient ID (if available), and contact information for shipper to rectify missing and/or ambiguous information.
Click here to see sample shipment requirements.
Any shipments missing this critical information will be put into quarantine and may experience extended turnaround times.
Join Discovery Life Sciences at Phacilitate's Advanced Therapies Week 2025, Jan 20-23 in Dallas! Visit us at Booth 161 and join Dr. Yuki Maves' presentation on Jan 23. Supply Chain: Future of Apheresis & Collections Location: Theater 5 Date/Time: Jan 23, Time TBD Schedule a Meeting at ATW
Join Discovery at Precision Medicine Tri-Con 2025.
Join Discovery at World CB & CDx Summit Europe 2025.
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing
